Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35705962)

  • 1. The power of heteronemin in cancers.
    Wang K; Chen YF; Yang YSH; Huang HM; Lee SY; Shih YJ; Li ZL; Whang-Peng J; Lin HY; Davis PJ
    J Biomed Sci; 2022 Jun; 29(1):41. PubMed ID: 35705962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells.
    Unson S; Chang TC; Yang YN; Wang SH; Huang CH; Crawford DR; Huang HM; Li ZL; Lin HY; Whang-Peng J; Wang K; Davis PJ; Li WS
    Mar Drugs; 2022 Jul; 20(8):. PubMed ID: 36005485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells.
    Huang CH; Huang TY; Chang WJ; Pan YS; Chu HR; Li ZL; Unson S; Chin YT; Lin CY; Huang HM; Hsiung CN; Gionfra F; De Vito P; Pedersen JZ; Incerpi S; Chen YR; Lee SY; Lin HY; Davis PJ; Whang-Peng J; Wang K
    Mar Drugs; 2020 Jul; 18(7):. PubMed ID: 32630719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition.
    Chung CC; Huang TY; Chu HR; De Luca R; Candelotti E; Huang CH; Yang YSH; Incerpi S; Pedersen JZ; Lin CY; Huang HM; Lee SY; Li ZL; ChangOu CA; Li WS; Davis PJ; Lin HY; Whang-Peng J; Wang K
    Food Chem Toxicol; 2022 Mar; 161():112850. PubMed ID: 35151786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heteronemin, a Marine Sesterterpenoid-Type Metabolite, Induces Apoptosis in Prostate LNcap Cells via Oxidative and ER Stress Combined with the Inhibition of Topoisomerase II and Hsp90.
    Lee MG; Liu YC; Lee YL; El-Shazly M; Lai KH; Shih SP; Ke SC; Hong MC; Du YC; Yang JC; Sung PJ; Wen ZH; Lu MC
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29890785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway.
    Lin HY; Tey SL; Ho Y; Chin YT; Wang K; Whang-Peng J; Shih YJ; Chen YR; Yang YN; Chen YC; Liu YC; Tang HY; Yang YS
    Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30563284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of l-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells.
    Lin HY; Chin YT; Nana AW; Shih YJ; Lai HY; Tang HY; Leinung M; Mousa SA; Davis PJ
    Steroids; 2016 Oct; 114():59-67. PubMed ID: 27221508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of Thyroid Hormones on Thyroid Cancers.
    Mousa SA; Hercbergs A; Lin HY; Keating KA; Davis PJ
    Front Endocrinol (Lausanne); 2021; 12():691736. PubMed ID: 34234745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Estrogen on Heteronemin-Induced Anti-proliferative Effect in Breast Cancer Cells With Different Estrogen Receptor Status.
    Yang YSH; Li ZL; Huang TY; Su KW; Lin CY; Huang CH; Chen HY; Lu MC; Huang HM; Lee SY; Whang-Peng J; Lin HY; Davis PJ; Wang K
    Front Cell Dev Biol; 2021; 9():688607. PubMed ID: 34381775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heteronemin promotes iron-dependent cell death in pancreatic cancer.
    Kaftan G; Erdoğan MA; El-Shazly M; Lu MC; Shih SP; Lin HY; Saso L; Armagan G
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1865-1874. PubMed ID: 37773525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells.
    Wu JC; Wang CT; Hung HC; Wu WJ; Wu DC; Chang MC; Sung PJ; Chou YW; Wen ZH; Tai MH
    Prostate; 2016 Dec; 76(16):1469-1483. PubMed ID: 27416770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breaking down Leukemia Walls: Heteronemin, a Sesterterpene Derivative, Induces Apoptosis in Leukemia Molt4 Cells through Oxidative Stress, Mitochondrial Dysfunction and Induction of Talin Expression.
    Chen YC; Lu MC; El-Shazly M; Lai KH; Wu TY; Hsu YM; Lee YL; Liu YC
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29914195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal Medicines Attenuate PD-L1 Expression to Induce Anti-Proliferation in Obesity-Related Cancers.
    Yang YSH; Li ZL; Shih YJ; Bennett JA; Whang-Peng J; Lin HY; Davis PJ; Wang K
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817534
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway.
    Su KW; Lin HY; Chiu HC; Shen SY; ChangOu CA; Crawford DR; Yang YSH; Shih YJ; Li ZL; Huang HM; Whang-Peng J; Ho Y; Wang K
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteronemin, a spongean sesterterpene, inhibits TNF alpha-induced NF-kappa B activation through proteasome inhibition and induces apoptotic cell death.
    Schumacher M; Cerella C; Eifes S; Chateauvieux S; Morceau F; Jaspars M; Dicato M; Diederich M
    Biochem Pharmacol; 2010 Feb; 79(4):610-22. PubMed ID: 19814997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrac as an anti-angiogenic agent in cancer.
    Schmohl KA; Nelson PJ; Spitzweg C
    Endocr Relat Cancer; 2019 Jun; 26(6):R287-R304. PubMed ID: 31063970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells.
    Chin YT; Wei PL; Ho Y; Nana AW; Changou CA; Chen YR; Yang YS; Hsieh MT; Hercbergs A; Davis PJ; Shih YJ; Lin HY
    Endocr Relat Cancer; 2018 May; 25(5):533-545. PubMed ID: 29555649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status.
    Lee YS; Chin YT; Yang YSH; Wei PL; Wu HC; Shih A; Lu YT; Pedersen JZ; Incerpi S; Liu LF; Lin HY; Davis PJ
    Steroids; 2016 Jul; 111():63-70. PubMed ID: 26980146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterisation of the anti-intravasative properties of the marine product heteronemin.
    Kopf S; Viola K; Atanasov AG; Jarukamjorn K; Rarova L; Kretschy N; Teichmann M; Vonach C; Saiko P; Giessrigl B; Huttary N; Raab I; Krieger S; Schumacher M; Diederich M; Strnad M; de Martin R; Szekeres T; Jäger W; Dirsch VM; Mikulits W; Grusch M; Dolznig H; Krupitza G
    Arch Toxicol; 2013 Oct; 87(10):1851-61. PubMed ID: 23543012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
    Davis PJ; Lin HY; Hercbergs A; Mousa SA
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.